Role of low-dose theophyllines in exacerbations of COPD
=======================================================

* A B Palamarthy

In the paper by Cosio and colleagues on the effect of low-dose theophylline on the anti-inflammatory effects of steroids during exacerbations of chronic obstructive pulmonary disease (COPD), the authors concluded that recovery of forced expiratory volume in 1 s 3 months after the exacerbation and low mortality (although not statistically significant) in the theophylline group, in combination with the molecular effects described, provided a strong rationale for investigating further the potential clinical relevance of this therapeutic strategy in large randomised double-blind placebo controlled trials.1

In such trials, if the time of hospital discharge is taken as the end point instead of taking 3 months after the exacerbation as in the study by Cosio *et al*, it would better reflect the physiological events of a COPD exacerbation. In addition to addressing the limitations expressed by the authors in the article, consideration of clinical parameters such as symptoms, blood gases and the need for non-invasive ventilation in the outcome measures might add more strength to the evidence. Another factor which also needs to be considered is whether patients with COPD are on a pulmonary rehabilitation programme.

## Footnotes

*   Competing interests None.

*   Provenance and peer review Not commissioned; not externally peer reviewed.

## Reference

1.  Cosio BG, Iglesias A, Rios A, et al. Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax 2009;64:424–9.
    
    [Abstract/FREE Full Text](http://thorax.bmj.com/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToidGhvcmF4am5sIjtzOjU6InJlc2lkIjtzOjg6IjY0LzUvNDI0IjtzOjQ6ImF0b20iO3M6MjY6Ii90aG9yYXhqbmwvNjUvMy8yNzcuMS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=)